Cargando…

A Case of Nivolumab-Induced Myositis

Nivolumab (Opdivo) is a monoclonal antibody classified as an immune modulator. A case is presented of nivolumab-induced myositis, an unlisted side effect.

Detalles Bibliográficos
Autores principales:	Fox, Eric, Dabrow, Michael, Ochsner, Greg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AlphaMed Press 2016
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153342/ https://www.ncbi.nlm.nih.gov/pubmed/27864576 http://dx.doi.org/10.1634/theoncologist.2016-0170

Ejemplares similares

Ipilimumab/nivolumab: Myocarditis-myositis overlap syndrome and ocular myositis: case report
Publicado: (2020)

Features of diaphragmatic myositis in a case of sudden infant death
por: Eisenhut, Michael
Publicado: (2011)

COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?
por: Movahedi, Nasim, et al.
Publicado: (2021)

Gemcitabine-induced myositis in a diabetes mellitus patient on hemodialysis
por: Chun, June Young, et al.
Publicado: (2017)

Nivolumab-Induced Myasthenia Gravis Concomitant With Myocarditis, Myositis, and Hepatitis
por: Bawek, Sawyer J, et al.
Publicado: (2021)

Myositis Ossificans of the Masseter Muscle
por: Kayal, L., et al.
Publicado: (2018)

A Case of Myositis Preceding Neuropathy in Eosinophilic Granulomatosis with Polyangiitis
por: Woo, Kyoungnam, et al.
Publicado: (2020)

Reply: Comment on alemtuzumab and inclusion body myositis
por: Dalakas, Marinos C., et al.
Publicado: (2010)

Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm
por: Haddox, C. L., et al.
Publicado: (2017)

Orbital myositis in systemic lupus erythematosus
por: Hernandez Fustes, Otto J.
Publicado: (2021)

Inclusion body myositis and Sjögren’s syndrome: the association works both ways
por: Giannini, Margherita, et al.
Publicado: (2022)

Near-Fatal Statin-Associated Autoimmune Myositis
por: Vithayathil, Mathew, et al.
Publicado: (2018)

Rimmed Vacuoles in Myositis Associated with Antimitochondrial Antibody
por: Shimazaki, Rui, et al.
Publicado: (2020)

Perioperative management of immune-mediated necrotizing myositis
por: Montané-Muntané, Mar, et al.
Publicado: (2022)

A Case of Focal Eosinophilic Myositis Associated with Hypereosinophilic Syndrome: A Rare Case Report
por: Jung, Joon Min, et al.
Publicado: (2015)

Nivolumab-induced eosinophilic fasciitis: a case report
por: Ollier, Natasha, et al.
Publicado: (2020)

Multifocal reactive myositis induced by Klebsiella pneumoniae
por: Escudero Siosi, Alexa, et al.
Publicado: (2021)

Acute orbital myositis before Herpes zoster ophthalmicus
por: Kim, Hyung Tae, et al.
Publicado: (2012)

Levator palpebrae superioris myositis: An uncommon cause of ptosis
por: Lai, Karen Hei-tung, et al.
Publicado: (2020)

Myelitis with Myositis - An Unusual Neurological Complication of COVID-19
por: Pereira, Amanda L., et al.
Publicado: (2022)

Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies
por: Watanabe, Shohei, et al.
Publicado: (2021)

Meningoencephalitis, myositis, and rash-neurological presentation of Indian tick typhus
por: Nigam, Gaurav, et al.
Publicado: (2016)

Anti-mitochondrial antibody-associated myositis with eosinophilia and dropped head
por: Shimizu, Hayato, et al.
Publicado: (2018)

Use of subcutaneous immunoglobulin in inflammatory myositis
por: Zhou, Alan L, et al.
Publicado: (2021)

A case report of nivolumab-induced myasthenia gravis and myositis in a metastatic renal cell carcinoma patient
por: Nakanishi, Shotaro, et al.
Publicado: (2019)

Thymoma-Associated Paraneoplastic Myositis, Presenting with Rapidly Progressive Muscle Contractures
por: Kim, Jin Hee, et al.
Publicado: (2021)

Nivolumab‐induced fulminant type 1 diabetes with precipitous fall in C‐peptide level
por: Miyauchi, Masaaki, et al.
Publicado: (2019)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
por: Huh, So-Young, et al.
Publicado: (2018)

Nivolumab-related myasthenia gravis with myositis requiring prolonged mechanical ventilation: a case report
por: Saishu, Yumi, et al.
Publicado: (2022)

Reactivation of COVID-19 pneumonia: A report of two cases
por: Ravioli, Svenja, et al.
Publicado: (2020)

An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma
por: Talreja, Vikas T., et al.
Publicado: (2019)

Acute viral myositis complicated by rhabdomyolysis: a sole manifestation of COVID-19 infection
por: Mughal, Mohsin Sheraz, et al.
Publicado: (2021)

Concomitant myasthenia gravis, myositis, myocarditis and polyneuropathy, induced by immune-checkpoint inhibitors: A life–threatening continuum of neuromuscular and cardiac toxicity
por: Rota, Eugenia, et al.
Publicado: (2018)

First Report of De Novo Nivolumab-Induced Oligoarthritis in a Young Man With Relapsing Classic Hodgkin Lymphoma
por: Galdiero, Maria Rosaria, et al.
Publicado: (2021)

Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
por: To, Fergus, et al.
Publicado: (2019)

Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis and nivolumab
por: Joob, Beuy, et al.
Publicado: (2022)

Spinal Cord and Motor Neuron TDP-43 Pathology in a Sporadic Inclusion Body Myositis Patient
por: Cathcart, Sahara J, et al.
Publicado: (2020)

The best dosage of nivolumab plus ipilimumab combination for melanoma brain metastases
por: Fukumoto, Takeshi, et al.
Publicado: (2022)

Inclusion body myositis in a patient with rheumatoid arthritis
por: Tariq, Mohammad, et al.
Publicado: (2018)

Sporadic inclusion body myositis (sIBM) in a patient with a history of diffuse large B-cell lymphoma
por: Advani, Soroor, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_99qg8mf81jq1g67j648j4sbq5a